Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands

  • Petr Šteiner
  • Simon Andreasen
  • Petr Grossmann
  • Lukáš Hauer
  • Tomáš Vaněček
  • Markéta Miesbauerová
  • Thalita Santana
  • Katalin Kiss
  • David Slouka
  • Alena Skálová
Original Article
  • 38 Downloads

Abstract

Adenoid cystic carcinoma (AdCC) of the salivary glands is characterized by MYB-NFIB or MYBL1-NFIB fusion, prolonged but relentlessly progressive clinical course with frequent recurrences, and development of distant metastasis resulting in high long-term mortality. Currently, no effective therapy is available for patients with advanced non-resectable and/or metastatic disease. Complicating the clinical management of this patient group is the lack of prognostic markers. The purpose of this study is to investigate the prognostic value of 1p36 loss in patients with AdCC. The presence of 1p36 deletion and gene fusions involving the MYB, NFIB, and MYBL1 genes in a cohort of 93 salivary gland AdCCs was studied using fluorescence in situ hybridization. These results were statistically correlated with clinical data and outcome. Deletion of 1p36 in AdCC was identified in 13 of 85 analyzable cases (15.29%). MYB-NFIB fusion was detected in 57/85 (67.1%), MYBL1-NFIB fusion in 12/85 (14.1%), MYB-X fusion in 4/85 (4.7%), MYBL1-X in 4/85 (4.7%), and NFIB-X in 2/85 (2.4%) of AdCC cases. None of the 1p36-deleted samples showed MYBL1 rearrangement. Statistical analysis demonstrated a significant correlation between 1p36 deletion and advanced tumor stage and solid histology (p = 0.0061 and 0.0007, respectively). Kaplan-Meier survival curves showed statistically significant correlations between 1p36 deletion and decreased overall survival, disease-specific survival, recurrence-free interval, and recurrence-free survival, all of which were maintained in multivariate analysis. We demonstrate that 1p36 deletion can serve as an indicator of unfavorable outcome of patients with salivary gland AdCC.

Keywords

Salivary gland Adenoid cystic carcinoma 1p36 locus deletion MYB-NFIB Prognosis 

Notes

Acknowledgements

We wish to thank Stanislav Kormunda for valuable assistance with statistical analysis.

Compliance with ethical standards

Study design has been approved by Danish Regional Ethics Committee (H-6-2014-086), the Danish Data Protection Agency (REG-94-2014), and local ethical committee of Charles University, Faculty of Medicine Plzen.

Conflicts of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Stenman G, Licitra L, Said-Al-Naief N, van Zante A, Yarborough W. Adenoid cystic carcinoma. In: El-Naggar A, Chan J, 2017 Grandis J, Takata T, Slootweg P (eds) World Health Organization classification of tumours. IARC Press, Lyon, 164–165Google Scholar
  2. 2.
    Skálová A, Stenman G, Simpson RHW, Hellquist H, Slouka D, Svoboda T, Bishop JA, Hunt JL, Nibu KI, Rinaldo A, Vander Poorten V, Devaney KO, Steiner P, Ferlito A (2017) The role of molecular testing in the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol.  https://doi.org/10.1097/PAS.0000000000000980
  3. 3.
    Bjørndal K, Krogdahl A, Therkildsen MH, Charabi B, Kristensen CA, Andersen E, Schytte S, Primdahl H, Johansen J, Pedersen HB, Andersen LJ, Godballe C (2015) Salivary adenoid cystic carcinoma in Denmark 1990-2005: outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 51:1138–1142.  https://doi.org/10.1016/j.oraloncology.2015.10.002 CrossRefPubMedGoogle Scholar
  4. 4.
    Godge P, Sharma S, Yadav M (2012) Adenoid cystic carcinoma of the parotid gland. Contemp Clin Dent 3:223–226.  https://doi.org/10.4103/0976-237X.96838 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A, Haigentz M, Takes RP, Mondin V, Teymoortash A, Thompson LD, Ferlito A (2015) Adenoid cystic carcinoma of the head and neck—an update. Oral Oncol 51:652–661.  https://doi.org/10.1016/j.oraloncology.2015.04.005 CrossRefPubMedGoogle Scholar
  6. 6.
    Persson M, Andrén Y, Mark J, Horlings HM, Persson F, Stenman G (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 106:18740–18744.  https://doi.org/10.1073/pnas.0909114106 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Brill LB, Kanner WA, Fehr A, Andrén Y, Moskaluk CA, Löning T, Stenman G, Frierson HF (2011) Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol 24:1169–1176.  https://doi.org/10.1038/modpathol.2011.86 CrossRefPubMedGoogle Scholar
  8. 8.
    Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, Weber RS, Caulin C, El-Naggar AK (2010) Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance. Clin Cancer Res 16:4722–4731.  https://doi.org/10.1158/1078-0432.CCR-10-0463 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S, Le QT (2011) MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol 35:92–99.  https://doi.org/10.1097/PAS.0b013e3182002777 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Xu B, Drill E, Ho A, Dunn L, Prieto-Granada CN, Chan T, Ganly I, Ghossein R, Katabi N (2017) Predictors of outcome in adenoid cystic carcinoma of salivary glands: a clinicopathologic study with correlation between MYB fusion and protein expression. Am J Surg Pathol 41:1422–1432.  https://doi.org/10.1097/PAS.0000000000000918 CrossRefPubMedGoogle Scholar
  11. 11.
    Brayer KJ, Frerich CA, Kang H, Ness SA (2016) Recurrent fusions in MYB and MYBL1 define a common, transcription factor-driven oncogenic pathway in salivary gland adenoid cystic carcinoma. Cancer Discov 6:176–187.  https://doi.org/10.1158/2159-8290.CD-15-0859 CrossRefPubMedGoogle Scholar
  12. 12.
    Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, El-Naggar AK (2016) Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clin Cancer Res 22:725–733.  https://doi.org/10.1158/1078-0432.CCR-15-2867-T CrossRefPubMedGoogle Scholar
  13. 13.
    Bernheim A, Toujani S, Saulnier P, Robert T, Casiraghi O, Validire P, Temam S, Menard P, Dessen P, Fouret P (2008) High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab Investig 88:464–473.  https://doi.org/10.1038/labinvest.2008.18 CrossRefPubMedGoogle Scholar
  14. 14.
    Freier K, Flechtenmacher C, Walch A, Ohl S, Devens F, Burke B, Hassfeld S, Lichter P, Joos S, Hofele C (2005) Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet 159:89–95.  https://doi.org/10.1016/j.cancergencyto.2004.09.007 CrossRefPubMedGoogle Scholar
  15. 15.
    Oga A, Uchida K, Nakao M, Kawauchi S, Furuya T, Chochi Y, Ikemoto K, Okada T, Ueyama Y, Sasaki K, Yousefpour F (2011) Loss of 6q or 8p23 is associated with the total number of DNA copy number aberrations in adenoid cystic carcinoma. Oncol Rep 26:1393–1398.  https://doi.org/10.3892/or.2011.1446 PubMedGoogle Scholar
  16. 16.
    Persson M, Andrén Y, Moskaluk CA, Frierson HF, Cooke SL, Futreal PA, Kling T, Nelander S, Nordkvist A, Persson F, Stenman G (2012) Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma. Genes Chromosom Cancer 51:805–817.  https://doi.org/10.1002/gcc.21965 CrossRefPubMedGoogle Scholar
  17. 17.
    Rettig EM, Talbot CC, Sausen M, Jones S, Bishop JA, Wood LD, Tokheim C, Niknafs N, Karchin R, Fertig EJ, Wheelan SJ, Marchionni L, Considine M, Fakhry C, Papadopoulos N, Kinzler KW, Vogelstein B, Ha PK, Agrawal N (2016) Whole-genome sequencing of salivary gland adenoid cystic carcinoma. Cancer Prev Res (Phila) 9:265–274.  https://doi.org/10.1158/1940-6207.CAPR-15-0316 Google Scholar
  18. 18.
    Seethala RR, Cieply K, Barnes EL, Dacic S (2011) Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation. Arch Pathol Lab Med 135:123–130.  https://doi.org/10.1043/2010-0048-OAR.1 PubMedGoogle Scholar
  19. 19.
    Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, Papaemmanuil E, Cheverton A, Bignell GR, Butler AP, Gamble J, Gamble S, Hardy C, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, McLaren S, McBride DJ, Menzies A, Mudie L, Maddison M, Raine K, Nik-Zainal S, O'Meara S, Teague JW, Varela I, Wedge DC, Whitmore I, Lippman SM, McDermott U, Stratton MR, Campbell PJ, El-Naggar AK, Futreal PA (2013) Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest 123:2965–2968.  https://doi.org/10.1172/JCI67201 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Tse DT, Finkelstein SD, Benedetto P, Dubovy S, Schiffman J, Feuer WJ (2006) Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol 141:54–61.  https://doi.org/10.1016/j.ajo.2005.09.002 CrossRefPubMedGoogle Scholar
  21. 21.
    Zhang L, Mitani Y, Caulin C, Rao PH, Kies MS, Saintigny P, Zhang N, Weber RS, Lippman SM, El-Naggar AK (2013) Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol 182:2048–2057.  https://doi.org/10.1016/j.ajpath.2013.02.020 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Bagchi A, Mills AA (2008) The quest for the 1p36 tumor suppressor. Cancer Res 68:2551–2556.  https://doi.org/10.1158/0008-5472.CAN-07-2095 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Henrich KO, Schwab M, Westermann F (2012) 1p36 tumor suppression—a matter of dosage? Cancer Res 72:6079–6088.  https://doi.org/10.1158/0008-5472.CAN-12-2230 CrossRefPubMedGoogle Scholar
  24. 24.
    Koshikawa K, Nomoto S, Yamashita K, Ishigure K, Takeda S, Nakao A (2004) Allelic imbalance at 1p36 in the pathogenesis of human hepatocellular carcinoma. Hepato-Gastroenterology 51:186–191PubMedGoogle Scholar
  25. 25.
    Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H (2003) Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:935–942.  https://doi.org/10.14670/HH-18.935 PubMedGoogle Scholar
  26. 26.
    Lefeuvre M, Gunduz M, Nagatsuka H, Gunduz E, Al Sheikh Ali M, Beder L, Fukushima K, Yamanaka N, Shimizu K, Nagai N (2009) Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomas. J Oral Pathol Med 38:94–98.  https://doi.org/10.1111/j.1600-0714.2008.00666.x CrossRefPubMedGoogle Scholar
  27. 27.
    Leonard JH, Cook AL, Nancarrow D, Hayward N, Van Gele M, Van Roy N, Speleman F (2000) Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma. Cancer Detect Prev 24:620–627PubMedGoogle Scholar
  28. 28.
    Midorikawa Y, Yamamoto S, Tsuji S, Kamimura N, Ishikawa S, Igarashi H, Makuuchi M, Kokudo N, Sugimura H, Aburatani H (2009) Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Hepatology 49:513–522.  https://doi.org/10.1002/hep.22698 CrossRefPubMedGoogle Scholar
  29. 29.
    van den Bent MJ (2000) Chemotherapy of oligodendroglial tumours: current developments. Forum (Genova) 10:108–118Google Scholar
  30. 30.
    Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, Weber RS, El-Naggar AK (2008) Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res 14:5181–5187.  https://doi.org/10.1158/1078-0432.CCR-08-0158 CrossRefPubMedGoogle Scholar
  31. 31.
    Andreasen S, Bishop JA, Hansen TV, Westra WH, Bilde A, von Buchwald C, Kiss K (2017) Human papillomavirus-related carcinoma with adenoid cystic-like features of the sinonasal tract: clinical and morphological characterization of six new cases. Histopathology 70:880–888.  https://doi.org/10.1111/his.13162 CrossRefPubMedGoogle Scholar
  32. 32.
    Mohapatra G, Betensky RA, Miller ER, Carey B, Gaumont LD, Engler DA, Louis DN (2006) Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization. J Mol Diagn 8:268–276.  https://doi.org/10.2353/jmoldx.2006.050109 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Perzin KH, Gullane P, Clairmont AC (1978) Adenoid cystic carcinomas arising in salivary-glands - correlation of histologic features and clinical course. Cancer 42:265–282.  https://doi.org/10.1002/1097-0142(197807)42:1<265::aid-cncr2820420141>3.0.co;2-z CrossRefPubMedGoogle Scholar
  34. 34.
    Szanto PA, Luna MA, Tortoledo ME, White RA (1984) Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 54:1062–1069CrossRefPubMedGoogle Scholar
  35. 35.
    Andersson MK, Afshari MK, Andrén Y, Wick MJ, Stenman G (2017) Targeting the oncogenic transcriptional regulator MYB in adenoid cystic carcinoma by inhibition of IGF1R/AKT signaling. J Natl Cancer Inst 109.  https://doi.org/10.1093/jnci/djx017
  36. 36.
    Andersson MK, Stenman G (2016) The landscape of gene fusions and somatic mutations in salivary gland neoplasms—implications for diagnosis and therapy. Oral Oncol 57:63–69.  https://doi.org/10.1016/j.oraloncology.2016.04.002 CrossRefPubMedGoogle Scholar
  37. 37.
    Andreasen S, Tan Q, Agander TK, Steiner P, Bjørndal K, Høgdall E, Larsen SR, Erentaite D, Olsen CH, Ulhøi BP, von Holstein SL, Wessel I, Heegaard S, Homøe P (2018) Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles. Mod Pathol.  https://doi.org/10.1038/s41379-018-0005-y
  38. 38.
    Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, Drobnjak M, Leversha MA, Rice CE, Singh B, Iyer NG, Leemans CR, Bloemena E, Ferris RL, Seethala RR, Gross BE, Liang Y, Sinha R, Peng L, Raphael BJ, Turcan S, Gong Y, Schultz N, Kim S, Chiosea S, Shah JP, Sander C, Lee W, Chan TA (2013) The mutational landscape of adenoid cystic carcinoma. Nat Genet 45:791–798.  https://doi.org/10.1038/ng.2643 CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Nordkvist A, Mark J, Gustafsson H, Bang G, Stenman G (1994) Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosom Cancer 10:115–121CrossRefPubMedGoogle Scholar
  40. 40.
    Stenman G (2013) Fusion oncogenes in salivary gland tumors: molecular and clinical consequences. Head Neck Pathol 7(Suppl 1):S12–S19.  https://doi.org/10.1007/s12105-013-0462-z CrossRefPubMedGoogle Scholar
  41. 41.
    Andreasen S, Persson M, Kiss K, Homøe P, Heegaard S, Stenman G (2016) Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland. Oncol Rep 35:2177–2182.  https://doi.org/10.3892/or.2016.4621 CrossRefPubMedGoogle Scholar
  42. 42.
    Geurts JM, Schoenmakers EF, Röijer E, Aström AK, Stenman G, van de Ven WJ (1998) Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene 16:865–872.  https://doi.org/10.1038/sj.onc.1201609 CrossRefPubMedGoogle Scholar
  43. 43.
    Chen TY, Keeney MG, Chintakuntlawar AV, Knutson DL, Kloft-Nelson S, Greipp PT, Garrity JA, Salomao DR, Garcia JJ (2017) Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement. Eye (Lond) 31:720–725.  https://doi.org/10.1038/eye.2016.307 CrossRefGoogle Scholar
  44. 44.
    D'Alfonso TM, Mosquera JM, MacDonald TY, Padilla J, Liu YF, Rubin MA, Shin SJ (2014) MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features. Hum Pathol 45:2270–2280.  https://doi.org/10.1016/j.humpath.2014.07.013 CrossRefPubMedGoogle Scholar
  45. 45.
    Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman SM, Caulin C, El-Naggar AK (2011) Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res 17:7003–7014.  https://doi.org/10.1158/1078-0432.CCR-11-1870 CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Roden AC, Greipp PT, Knutson DL, Kloft-Nelson SM, Jenkins SM, Marks RS, Aubry MC, García JJ (2015) Histopathologic and cytogenetic features of pulmonary adenoid cystic carcinoma. J Thorac Oncol 10:1570–1575.  https://doi.org/10.1097/JTO.0000000000000656 CrossRefPubMedGoogle Scholar
  47. 47.
    Costa AF, Altemani A, Vékony H, Bloemena E, Fresno F, Suárez C, Llorente JL, Hermsen M (2010) Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type. Anal Cell Pathol (Amst) 33:217–228.  https://doi.org/10.3233/ACP-CLO-2010-0547 CrossRefGoogle Scholar
  48. 48.
    Ferrarotto R, Mitani Y, Diao L, Guijarro I, Wang J, Zweidler-McKay P, Bell D, William WN, Glisson BS, Wick MJ, Kapoun AM, Patnaik A, Eckhardt G, Munster P, Faoro L, Dupont J, Lee JJ, Futreal A, El-Naggar AK, Heymach JV (2017) Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors. J Clin Oncol 35:352–360.  https://doi.org/10.1200/JCO.2016.67.5264 CrossRefPubMedGoogle Scholar
  49. 49.
    Sajed DP, Faquin WC, Carey C, Severson EA, Afrogheh A, Johnson CA, Blacklow SC, Chau NG, Lin DT, Krane JF, Jo VY, Garcia JJ, Sholl LM, Aster JC (2017) Diffuse staining for activated notch1 correlates with notch1 mutation status and is associated with worse outcome in adenoid cystic carcinoma. Am J Surg Pathol 41:1473–1482.  https://doi.org/10.1097/PAS.0000000000000945 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Petr Šteiner
    • 1
    • 2
  • Simon Andreasen
    • 3
    • 4
  • Petr Grossmann
    • 2
  • Lukáš Hauer
    • 5
  • Tomáš Vaněček
    • 1
    • 2
  • Markéta Miesbauerová
    • 1
  • Thalita Santana
    • 6
  • Katalin Kiss
    • 7
  • David Slouka
    • 8
  • Alena Skálová
    • 1
  1. 1.Department of Pathology, Faculty of Medicine in PlzenCharles UniversityPlzenCzech Republic
  2. 2.Bioptic Laboratory, Ltd, Molecular Pathology LaboratoryPlzenCzech Republic
  3. 3.Department of Otorhinolaryngology Head and Neck Surgery and Audiology, RigshospitaletCopenhagen University HospitalCopenhagenDenmark
  4. 4.Department of Otorhinolaryngology and Maxillofacial SurgeryZealand University HospitalKøgeDenmark
  5. 5.Department of Maxillofacial Surgery, Faculty of Medicine in Plzen, Clinic of DentistryCharles UniversityPlzenCzech Republic
  6. 6.Department of Oral Pathology, Faculty of DentistryUniversity of São PauloSão PauloBrazil
  7. 7.Department of Pathology, RigshospitaletCopenhagen University HospitalCopenhagenDenmark
  8. 8.Department of Otorhinolaryngology, Faculty of Medicine in PlzenCharles UniversityPlzenCzech Republic

Personalised recommendations